U.S. pharma huge copyright scrapped two experimental weight loss supplements past calendar year—a after-each day pill, lotiglipron, on account of elevated liver enzymes plus a twice-daily tablet, danuglipron, as a consequence of strong Uncomfortable side effects—but CEO Albert Bourla